A detailed history of Mufg Securities Emea PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mufg Securities Emea PLC holds 149,999 shares of ABBV stock, worth $29.2 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
149,999
Holding current value
$29.2 Million
% of portfolio
1.15%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $23.2 Million - $27.1 Million
149,999 New
149,999 $25.7 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $19.3 Million - $21.7 Million
140,000 New
140,000 $21.7 Million
Q2 2023

Aug 03, 2023

BUY
$132.51 - $164.9 $19.7 Million - $24.5 Million
148,665 New
148,665 $20 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $12,661 - $16,096
-92 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $93,705 - $116,262
-710 Reduced 88.53%
92 $15,000
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $26.3 Million - $33.3 Million
-244,998 Reduced 99.67%
802 $109,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $25.5 Million - $28.9 Million
-239,500 Reduced 49.35%
245,800 $26.5 Million
Q2 2021

Jul 19, 2021

BUY
$105.21 - $117.21 $25.7 Million - $28.6 Million
244,121 Added 101.22%
485,300 $54.7 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $31.1 Million - $34.2 Million
-303,821 Reduced 55.75%
241,179 $26.1 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $28.2 Million - $38.1 Million
350,556 Added 180.29%
545,000 $58.4 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $25.9 Million - $30.4 Million
-301,600 Reduced 60.8%
194,444 $17 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $36.4 Million - $48.7 Million
496,044 New
496,044 $48.7 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $24.1 Million - $29 Million
-382,899 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $5.45 Million - $6.96 Million
82,899 Added 27.63%
382,899 $27.8 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $18.9 Million - $22.2 Million
245,000 Added 445.45%
300,000 $24.2 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $5.38 Million - $6.63 Million
-69,051 Reduced 55.66%
55,000 $5.07 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $10.9 Million - $12.1 Million
122,353 Added 7205.71%
124,051 $11.7 Million
Q2 2018

Aug 01, 2018

BUY
$89.78 - $106.23 $152,446 - $180,378
1,698 New
1,698 $157,000
Q1 2018

May 01, 2018

SELL
$92.01 - $123.21 $27.6 Million - $37 Million
-300,000 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$89.56 - $98.21 $26.9 Million - $29.5 Million
300,000
300,000 $29 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mufg Securities Emea PLC Portfolio

Follow Mufg Securities Emea PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Securities Emea PLC with notifications on news.